BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10524961)

  • 1. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.
    Shortridge VD; Doern GV; Brueggemann AB; Beyer JM; Flamm RK
    Clin Infect Dis; 1999 Nov; 29(5):1186-8. PubMed ID: 10524961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment.
    Gay K; Baughman W; Miller Y; Jackson D; Whitney CG; Schuchat A; Farley MM; Tenover F; Stephens DS
    J Infect Dis; 2000 Nov; 182(5):1417-24. PubMed ID: 11023465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.
    Ambrose KD; Nisbet R; Stephens DS
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4203-9. PubMed ID: 16189099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
    Farrell DJ; File TM; Jenkins SG
    J Clin Microbiol; 2007 Feb; 45(2):290-3. PubMed ID: 17093012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of macrolide-resistant Streptococcus pneumoniae-expressing mefE or ermB gene in the nasopharynx among children with otitis media.
    Hotomi M; Billal DS; Shimada J; Suzumoto M; Yamauchi K; Fujihara K; Yamanaka N
    Laryngoscope; 2005 Feb; 115(2):317-20. PubMed ID: 15689758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance in Streptococcus pneumoniae in Hong Kong.
    Ip M; Lyon DJ; Yung RW; Chan C; Cheng AF
    Antimicrob Agents Chemother; 2001 May; 45(5):1578-80. PubMed ID: 11302833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.
    Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A
    Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between usage of macrolide antibiotic and resistance of Streptococcus pneumoniae clinic isolates from Chongqing children's hospital.
    Chen J; Liu L; Wang G; Chen Y; Luo Z; Huang Y; Fu Z; Yang Y; Liu E
    Pediatr Pulmonol; 2009 Sep; 44(9):917-21. PubMed ID: 19670405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
    Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.
    Lynch III JP; Martinez FJ
    Clin Infect Dis; 2002 Mar; 34 Suppl 1():S27-46. PubMed ID: 11810608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.